If you have been reading about mass spectrometry and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-01-05. Where a claim depends on a specific study, the study is described rather than over-claimed.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
| Property | Value | Notes |
|---|---|---|
| Appearance as powder | White to off-white solid | Minor batch-to-batch variation is normal |
| Solubility class | Soluble in water and aqueous buffers | Dissolution can be slowed by aggregates |
| Typical storage temperature | Minus 20 degrees Celsius or below | Protected from light and moisture |
| Storage after reconstitution | 2 to 8 degrees Celsius, short term | Longer holding requires freezing |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity and identity confirmation |
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
While in graduate school in the 1960s she began working on corticotropin, and while trying to purify this hormone later in her career she made a chance finding of a peptide called substance P. This event subsequently led to her life's work of researching substance P and another peptide she chemically isolated and defined, neurotensin.
=== Significance for the origin of life === Nitriles may have played a significant role in chemical evolution on Earth. Experimental studies have demonstrated that hydrogen cyanide can form under a wide range of plausible prebiotic conditions. Possible starting materials include gas mixtures of methane, carbon dioxide, nitrogen, ammonia, and/or hydrogen. Various energy sources, such as electrical discharges or ultraviolet radiation, are likewise conceivable. Under simple conditions, hydrogen cyanide can give rise to numerous additional organic molecules. Hydrogen cyanide and other nitriles, such as cyanoacetylene and dicyan, are considered potential precursors of nucleic bases. Aminonitriles, in turn, are regarded as likely precursors of amino acids and peptides; for example, aminoacetonitrile is a precursor of glycine. An analogous process to the Strecker synthesis is proposed, in which α-aminopropionitrile initially forms from cyanide, acetaldehyde, and ammonia and is subsequently hydrolyzed to alanine.
The metabolism of drugs is mainly by metabolic enzyme cytochrome P450, and this enzyme is not active in skin. The CYP450 actively metabolized drugs can then maintain high concentration when being applied on skin. Despite CYP450 enzyme action, the partition coefficient (K) determines the activity of topical drugs. The ability of drug particles to go through the skin layer also affects the absorption of drugs. For transdermal activity, medicines with higher K value are harder to get rid of the lipid layer of skin cells. The trapped molecules then cannot penetrate into the skin. This reduces the efficacy of the transdermal drugs. The drugs target cells underneath the skin or need to diffuse into blood capillary to exert their effect. Meanwhile, the size of particles affects this transdermal process. The smaller the drug molecules, the faster the rate of penetration. Polarity of the drugs can affect this diffusion rate too. If the drug shows lower degree of ionization, it is less polar. Therefore, it can have a faster absorption rate.
== Professional activities == After earning a Ph.D. degree in biochemistry, a medical degree, and completing a research postdoctoral fellowship at the University of Wisconsin–Madison, Holick completed a residency in medicine at the Massachusetts General Hospital in Boston. He has been practicing adult and pediatric endocrinology since 1978 and is professor of medicine, physiology and biophysics and director of the Bone Health Care Clinic and the Heliotherapy, Light, and Skin Research Center at Boston University Medical Center. It provides extensive evaluation and treatment programs for children and adults with various metabolic bone diseases including osteoporosis, osteomalacia, stress fractures in young athletic women and men, and minimum trauma and nontraumatic fractures in infants, children and adults with hypermobility syndromes, osteogenesis imperfecta, and Ehlers–Danlos syndrome. He has been director of the General Clinical Research Unit at Boston University for several years. Holick serves as chair of NASA's "Human Health Countermeasures Element" Standing Review Panel, chair of the Endocrine Practice Guidelines Committee for Vitamin D, and editor-in-chief of the medical journal Clinical Laboratory.
Sources: en.wikipedia.org
=== Excessive sleepiness === Selegiline has been evaluated for the treatment of narcolepsy in three small clinical studies. It was found to be effective in these studies. A dosage of 10 mg/day had no effect on symptoms, but 20 to 30 mg/day improved alertness, mood, and somewhat reduced cataplexy, clinical effects that have been described as comparable to the same dosages of amphetamine. Animal research indicates that the beneficial effects of high doses of selegiline in narcolepsy are likely due to conversion into its active metabolites, levoamphetamine and levomethamphetamine. Selegiline has also been evaluated for treatment of hypersomnia (excessive sleeping or sleepiness) in people with myotonic dystrophy, but its effectiveness was very uncertain.
=== September === 4 September – The ESA/JAXA BepiColombo mission performs the closest ever flyby of a planet, as it speeds past Mercury at a distance of just 165 km (103 mi). 10 September – Researchers in Sweden demonstrate a battery made of carbon fibre composite as stiff as aluminium and energy-dense enough to be used commercially. 11 September A study finds that the bluestreak cleaner wrasse (Labroides dimidiatus), a small tropical fish, may possess a form of self-awareness. The Jülich Supercomputing Centre in Germany announces the start of installation for JUPITER, Europe's first exascale supercomputer. 12 September OpenAI releases its "o1" series of large language models (LLMs), featuring improved capabilities in coding, math, science and other complex tasks. Jared Isaacman and Sarah Gillis complete the first commercial spacewalk and test slimmed-down spacesuits designed by SpaceX. A study suggests Earth had planetary rings during the Ordovician period, formed from the breakup of an asteroid, from which material deorbited during the ~40 million years long Ordovician meteor event ~466 million years ago, resulting in an otherwise unlikely crater distribution. A policy study finds bans of food waste disposals in landfills, which produce very large amounts of greenhouse gases, in five U.S. states had almost no effect with the exception of the state of Massachusetts. It suggests several makings that may have contributed to that states' success.
=== Insect decline === Both number of insects and number of insect species have declined dramatically and continuously over past decades, causing much concern. Many causes are proposed to contribute to this decline, the most agreed upon are loss of habitat, intensification of farming practices, and insecticide usage. Domestic bees were declining some years ago but population and number of colonies have now risen both in the USA and worldwide. Wild species of bees are still declining.
On 21 July 2011, following the exclusion of the original Salernitana club, Salerno mayor Vincenzo De Luca, in compliance with Article 52 of N.O.I.F., assigned the new title to Marco Mezzaroma, brother-in-law of Lazio owner and chairman Claudio Lotito. The new club was admitted to Serie D under the denomination of Salerno Calcio. In the 2011–12 season, Salernitana was immediately promoted to Lega Pro Seconda Divisione after winning Group G of Serie D. On 12 July 2012, the club was renamed US Salernitana 1919. In the 2012–13 Lega Pro Seconda Divisione season, Salernitana finished first in Girone B, and was promoted to Lega Pro Prima Divisione. This was the second consecutive promotion for the team. Finally Salernitana won Group C of Lega Pro and returned Serie B in 2014–15 season. After several seasons at Serie B level, Salernitana won promotion to Serie A at the end of the 2020–21 Serie B season under the tenure of head coach Fabrizio Castori, finishing in 2nd place behind champions Empoli. Promotion was secured with a 3–0 victory over Pescara on the final matchday. Salernitana's return to Serie A however required Lotito and Mezzaroma to sell the club, due to Italian football laws not allowing two clubs from the same owner to play in the same league. On 7 July 2021, the FIGC Federal Council approved the trust of Salernitana to take control of the club, meaning it was officially enrolled in Serie A for the first time in 23 years.
==== Bipolar disorder ==== In bipolar disorder, N-acetylcysteine has been repurposed as an augmentation strategy for depressive episodes in light of the possible role of inflammation in the pathogenesis of mood disorders. Nonetheless, meta-analytic evidence shows that add-on N-acetylcysteine was more effective than placebo only in reducing depression scales scores (low quality evidence), without positive effects on response and remission outcomes, limiting its possible role in clinical practice to date.
Sources: en.wikipedia.org
==== Dominican Republic ==== Collaborative efforts between the Dominican Republic and US anti-drug agencies have been conducted, recovering numerous packages of cocaine. On 26 November, during a meeting with Hegseth, Dominican president Luis Abinader granted the US temporary authorization to use San Isidro Air Base and the Las Americas International Airport for its counter-narcotics operations. By mid-December, the US had moved more specialized military assets to Puerto Rico and the Dominican Republic that would support targeted land strikes, seizures of oil tankers or enforcement of an oil embargo. TheWarZone.com described the addition of refueling and search and rescue aircraft as "moving into a posture ... for tactical air combat operations over hostile territory"; the deployment of EA–18G Growlers as "indicative of what one would see in the lead-up to a kinetic operation centered heavily on strikes on targets in inland areas" with "electronic warfare support for platforms launching standoff attacks or penetrating through enemy air defenses"; and deployment of F-35s as preparing for airstrikes "on targets deep inside Venezuelan airspace".
At the end of the meet, the Texas Longhorns took second while 2007's champion, the Auburn Tigers, took fifth. For the women, Arizona worked on the disappointment of 2007's defeat. The women were winning until the last day when Auburn grasped the title. Unlike 2007, Arizona's women did not let anyone come close. The Wildcats won with 484 team points while the Auburn Tigers came in second with 348 and the Stanford Cardinal in third with 343. Student-athletes from the women's swimming and diving team have been particularly heralded by the NCAA. The NCAA Woman of the Year Award was won by UA swimmers Whitney Myers, Lacey Nymeyer and Justine Schluntz in 2007, 2009 and 2010 respectively. The three awards and the 1994 award won by track and field athlete Tanya Hughes are the highest number of Woman of the Year awards won by a single university.
== External links == FDA regulation on the use of TTI's in the seafood industry. Article on the introduction of a TTI at a large food producer Archived 2018-08-14 at the Wayback Machine WRAP Food Waste Report (1.4 MB) WHO Factsheet on the global amount of food related illnesses Article on the introduction of a TTI at a food producer in Switzerland
=== Antivenene research and production === In 1928, CSL also became involved in antivenene (antivenom) manufacture in conjunction with the snake venom research undertaken by Charles Kellaway at the Hall Institute. This led to the successful clinical testing of antivenene against tiger snake Notechis scutatus bite in 1930 and its commercial release in 1931. In 1934, the research on snake venoms was transferred from the Hall Institute to CSL under the direction of former snake showman and herpetologist Tom "Pambo" Eades. This represented the initiation of research at the laboratories – an outcome its directors had been seeking for over a decade. The relationship with the Hall Institute continued until World War II, particularly via joint projects on viral diseases including polio and influenza coordinated by Frank Macfarlane Burnet and Esmond "Bill" Keogh. Keogh played an important role in the establishment of penicillin production at CSL in 1944 – a critical wartime achievement.
The Ayrshire and Simmental breeds were imported first, followed by the Brown Swiss, but few people wanted to crossbreed with them because of their large size, and the Japanese government encouraged it, but the crossbreds were very unpopular. The crossbreds' oversized stature made them inconvenient for Japan's narrow arable land, and their movements were slow and sluggish, and their temperaments were rough and lacking in obedience. They also had poor meat quality and were condemned from all quarters as being unsuitable for sukiyaki. As a result, from around 1907, there were no more crossbreds being bred, and in reaction, the old black cattle were considered good, and as long as they were small and black, they could be sold. As crossbreeding with Western breeds progressed, the term "pure Wagyu" (純粋和牛, junsui Wagyū) emerged to describe native Japanese cattle, and by 1912, it was claimed that there were two definitions of Wagyu: "pure Wagyu" and "improved Wagyu" (改良和牛, kairyō Wagyū). At that time, Mendel's laws had just been rediscovered, and both the Japanese government and cattle farmers lacked sufficient knowledge of genetics. The unpopularity of crossbred cattle led to the Japanese government's decision in 1911 to suspend plans to purchase Brown Swiss and Simmental cattle. In 1912, the Japanese government decided to formally end its policy of encouraging crossbreeding by announcing that crossbreeding between Wagyu and European breeds had been sufficiently successful. From then on, Wagyu improvement was based on pure Wagyu and improved Wagyu (crossbred cattle).
Sources: en.wikipedia.org
Chromatography reports how much material elutes as a single peak but does not confirm what that material is. Mass spectrometry supplies the molecular mass, which is characteristic of a given sequence and its modifications. Together the two methods support both a purity figure and an identity claim.
Hydrolysis, oxidation of susceptible residues, and aggregation all contribute, and their rates depend on pH, temperature, and concentration. Dissolved oxygen and trace metal ions accelerate oxidation. Keeping solutions cold, dilute, and free of unnecessary handling reduces these pathways.
Not always, because the value depends on the detection wavelength, the gradient, and how peak areas are integrated. A figure of ninety-eight percent from one laboratory may not mean the same as the same number from another. Comparing full chromatograms and mass spectra is more informative than comparing a single number.
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.